Watchlist Price Alert

Sonoma Pharmaceuticals In... (SNOA)

NASDAQ: SNOA · Real-Time Price · USD

3.21

0.03 (0.94%)

At close: May 16, 2025, 3:59 PM

3.18

-0.93%

After-hours: May 16, 2025, 07:45 PM EDT

Sonoma Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is April - March.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016
Cash & Equivalents	3.13M	3.82M	7.4M	4.22M	3.69M	3.69M	10.07M	17.46M	7.47M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	396K	578K	707K	875K	850K	1.23M	1.82M	1.58M	65K
Receivables	2.9M	2.57M	2.41M	2.81M	3.97M	3.48M	1.54M	2.11M	1.51M
Inventory	2.72M	2.86M	2.66M	2.53M	2.19M	3.41M	2.87M	2.22M	1.64M
Other Current Assets	367K	240K	218K	209K	182K	223K	239K	237K	811K
Total Current Assets	12.55M	13.8M	16.43M	12.98M	12.38M	12.5M	16.25M	22.64M	12.89M
Property-Plant & Equipment	651K	906K	879K	1.13M	1.33M	727K	1.14M	1.24M	850K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	2.19M	2.43M	2.42M	2M	2.18M	1.95M	2.95M	2.82M	915K
Total Assets	14.74M	16.23M	18.84M	14.99M	14.56M	14.45M	19.21M	25.46M	13.8M
Account Payables	607K	841K	1.64M	1.77M	2.07M	1.25M	1.27M	1.25M	1.34M
Deferred Revenue	478K	160K	1.28M	319K	273K	102K	206K	521K	574K
Short-Term Debt	323K	687K	808K	836K	481K	322K	230K	123K	114K
Other Current Liabilities	694K	310K	784K	127K	1.39M	814K	1.18M	1.24M	850K
Total Current Liabilities	3.72M	3.72M	5.82M	4.08M	4.87M	3.59M	3.26M	3.29M	3.55M
Long-Term Debt	n/a	n/a	n/a	1.31M	n/a	12K	32K	45K	n/a
Other Long-Term Liabilities	4.71M	4.24M	3.84M	3.48M	3.73M	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	4.88M	4.54M	4.33M	5.55M	991K	368K	619K	740K	112K
Total Liabilities	8.6M	8.25M	10.15M	9.62M	5.86M	3.96M	3.88M	4.03M	3.66M
Total Debt	608K	849K	1.37M	2.67M	1.48M	475K	553K	410K	114K
Common Stock	2K	5K	2K	2K	2K	2K	1K	1K	2K
Retained Earnings	-194.35M	-189.51M	-184.36M	-179.28M	-172.25M	-169.24M	-157.44M	-143.1M	-152.38M
Comprehensive Income	-2.72M	-3.42M	-4.31M	-4.58M	-5.61M	-4.35M	-3.98M	-4.18M	-3.85M
Shareholders Equity	6.14M	7.98M	8.7M	5.36M	8.71M	10.49M	15.33M	21.43M	10.14M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a